Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PATH +11.7%, STRZ +8.7%, ULTA +8%, SCVL +6.4%, TIGR +4.5%, ZS +4% (also names new CFO), AMBA +1.3%, DELL +0.9%, MCHP +0.6%
Other news:
- RUSHA +5% (increases stock repurchase program by $50 mln)
- RBB +3.5% (authorizes new $18 mln share repurchase program)
- SBCF +3.2% (to acquire Villages Bancorporation)
- BF.A +1.8% (completes RFP process for portfolio distribution in select markets)
- CSTL +1.8% (reports new data)
- SCHL +1.3% (to integrate some divisions into new, combined Children's Book Group)
- BEAM +1.2% (FDA grants Orphan Drug Designation for BEAM-302)
- ZYME +1.2% (receives NMPA approval of Zanidatamab in China)
- XRAY +1% (names new CFO)
- SKY +0.8% (authorized an increase of $50 mln to existing share repurchase program, bringing the aggregate capacity of the program to $150 mln)